Healthpeak Properties (DOC) Dropped, So What Is Driving Attention Today?

Healthpeak Properties (DOC) is back in focus after second quarter 2026 earnings and a higher full year earnings outlook, a combination that is prompting investors to reassess both the stock and its risk profile.

See our latest analysis for Healthpeak Properties.

Healthpeak Properties shares have eased in the short term, with the 1 month share price return down 3.46% and the 7 day share price return down 3.42%. However, the year to date share price return of 29.01% and 1 year total shareholder return of 33.34% still point to momentum that has built ahead of and around the stronger quarterly earnings, raised 2026 guidance, and recent options activity that suggests investors are actively reassessing the company’s risk and return profile.

If stronger guidance in healthcare real estate has your attention, this can be a good moment to broaden your watchlist and check out 19 top founder-led companies

Healthpeak Properties now trades below both intrinsic value estimates and the average analyst target, even after a strong run. Is that a simple discount to fair value, or a sign that the market’s caution on its risk profile still matters?

Most Popular Narrative: 3% Undervalued

The most followed narrative currently places Healthpeak Properties' fair value at $21.44, slightly above the last close at $20.90. That small gap is enough to raise questions about what is built into the long term earnings assumptions behind that number.

The analysts have a consensus price target of $21.44 for Healthpeak Properties based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $29.0, and the most bearish reporting a price target of just $17.0.

Read the complete narrative.

The gap between those analyst views is not random. It rests on specific calls around revenue growth, margin direction, and how rich a future earnings multiple Healthpeak Properties can support. Curious which assumptions really drive that $21.44 fair value and how sensitive it is to small changes in the outlook.

Result: Fair Value of $21.44 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Healthpeak Properties narrative still faces pressure from potential tenant weakness in biotech and the risk that higher refinancing costs will squeeze margins and cash flows.

Find out about the key risks to this Healthpeak Properties narrative.

Another View on Healthpeak Properties Valuation

The narrative around Healthpeak Properties leans on analyst fair value and long term earnings assumptions. The market snapshot tells a different story. The stock trades on a P/E of 59.4x compared with a fair ratio of 18.5x, a US Health Care REITs average of 47.9x and a global sector average of 17.4x. That is a wide gap. It points to meaningful valuation risk if sentiment or growth expectations ease, even with an intrinsic value estimate above the current $20.90 share price. Which signal do you think matters more right now: the discount to fair value or the premium multiple the market is already paying?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment on Healthpeak Properties is clearly mixed, with both risks and rewards in play. It makes sense to move quickly and review the underlying data yourself. To weigh both sides with a clear view of what stands out most, start with the 2 key rewards and 4 important warning signs.

Looking for more investment ideas beyond Healthpeak Properties?

If you are reassessing Healthpeak Properties today, this is also a smart time to widen your opportunity set with fresh stock ideas built from clear fundamentals.

• Spot potential value opportunities early by checking companies that screen well on quality and price using the 51 high quality undervalued stocks.
• Grow your income stream with stocks that focus on reliable cash returns by reviewing the 9 dividend fortresses.
• Prioritize resilience by zeroing in on companies that score well for financial strength through the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com